Hepatitis B Detection

New test quickly identifies both surface and e antigen of hepatitis B

Published in Hepatitis Weekly, December 30th, 2002

by Sonia Nichols, senior medical writer - A new test evaluated by researchers in Ghent, Belgium can quickly and accurately identify hepatitis B virus (HBV) surface and e antigen.

The test can discriminate between active or carrier status. It should allow for rapid identification of people who would benefit from either vaccination or treatment say researchers who evaluated the test, which was developed by Binax, Inc., of Portland, Maine.

Researchers at Ghent University and Hospital in Belgium used the HBsAg/eAg test on 942 serum samples. "The clinical sensitivity of the HBsAg/eAg test was 99.75% and 96.37% for HBsAg and HBeAg, respectively," F....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2002-12-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry